| scholarly article | Q13442814 |
| P2093 | author name string | Jie Zhang | |
| Ling Yang | |||
| Chun Yang | |||
| Bin Zhu | |||
| Jin-Feng Liu | |||
| Li-Ying Miao | |||
| Ri-Yue Jiang | |||
| Li-Na Jin | |||
| Ai-Lin Luo | |||
| Jian-Qin Shen | |||
| P2860 | cites work | Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease | Q33683071 |
| Evidence for anti-inflammatory effects of exercise in CKD. | Q34103416 | ||
| Life extension factor klotho enhances cognition | Q34252649 | ||
| The Central American epidemic of CKD. | Q34308302 | ||
| Small-molecule Klotho enhancers as novel treatment of neurodegeneration | Q34394061 | ||
| Riluzole stimulates BDNF release from human platelets | Q34988697 | ||
| Cognitive function and all-cause mortality in maintenance hemodialysis patients | Q35009610 | ||
| Cost-effectiveness of primary screening for CKD: a systematic review. | Q35094743 | ||
| Role of Klotho in aging, phosphate metabolism, and CKD. | Q35318410 | ||
| FGF-23 and cognitive performance in hemodialysis patients | Q35647125 | ||
| FGF-23 serum levels and bone histomorphometric results in adult patients with chronic kidney disease on dialysis | Q35949319 | ||
| The Montreal Cognitive Assessment (MoCA) is superior to the Mini Mental State Examination (MMSE) in detection of Korsakoff's syndrome. | Q50621290 | ||
| Risk factors for cognitive dysfunction in CKD and hypertensive subjects. | Q51026220 | ||
| The Montreal Cognitive Assessment: validity and utility in a memory clinic setting. | Q51902941 | ||
| Hypoplastic left heart syndrome with premature closure of foramen ovale: report of an unusual type of totally anomalous pulmonary venous return | Q68819042 | ||
| Effect of hemodialysis on platelet function in end-stage renal disease Egyptian patients using in vitro closure time test (PFA-100 analyzer) | Q88134189 | ||
| Regulating billions of blood platelets: glycans and beyond. | Q36169258 | ||
| Association between Serum Soluble Klotho Levels and Mortality in Chronic Hemodialysis Patients | Q36269865 | ||
| Plasma brain-derived neurotrophic factor in hemodialysis patients | Q36378196 | ||
| Effects of three blood purification methods on serum fibroblast growth factor-23 clearance in patients with hyperphosphatemia undergoing maintenance hemodialysis | Q37661721 | ||
| Review: microglia of the aged brain: primed to be activated and resistant to regulation | Q38049597 | ||
| BDNF-induced local protein synthesis and synaptic plasticity | Q38100505 | ||
| Nephrology in china | Q38123395 | ||
| Dementia and mild cognitive impairment in adults with intellectual disability: issues of diagnosis | Q38129323 | ||
| Cognitive impairment in chronic kidney disease: clinical findings, risk factors and consequences for patient care | Q38180990 | ||
| BDNF and synaptic plasticity, cognitive function, and dysfunction | Q38199414 | ||
| Chewing Maintains Hippocampus-Dependent Cognitive Function | Q38528894 | ||
| Metabolic Acidosis of CKD: An Update | Q38610302 | ||
| Timing of dialysis initiation, duration and frequency of hemodialysis sessions, and membrane flux: a systematic review for a KDOQI clinical practice guideline | Q38615712 | ||
| KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 update | Q38615714 | ||
| Prevalence and risk factors of cognitive dysfunction in chronic hemodialysis patients | Q38997516 | ||
| Variability of cognitive performance during hemodialysis: standardization of cognitive assessment | Q39247255 | ||
| Regional differences in brain-derived neurotrophic factor levels and dendritic spine density confer resilience to inescapable stress | Q39272870 | ||
| Endostatin, Cathepsin S, and Cathepsin L, and Their Association with Inflammatory Markers and Mortality in Patients Undergoing Hemodialysis | Q40997513 | ||
| Decreased mean platelet volume and platelet distribution width are associated with mild cognitive impairment and Alzheimer's disease | Q44004831 | ||
| Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment | Q44355265 | ||
| Phase-dependent response of the lung to NO2 irritant insult. | Q44566956 | ||
| Cognitive-behavioral therapy for sleep disturbance decreases inflammatory cytokines and oxidative stress in hemodialysis patients. | Q48298837 | ||
| Hemodialysis decreases serum brain-derived neurotrophic factor concentration in humans | Q48405135 | ||
| Human platelet concentrates: a source of solvent/detergent-treated highly enriched brain-derived neurotrophic factor | Q48733918 | ||
| Fibroblast growth factor 23 signaling in hippocampal cells: impact on neuronal morphology and synaptic density. | Q48891787 | ||
| Release reaction of brain-derived neurotrophic factor (BDNF) through PAR1 activation and its two distinct pools in human platelets | Q48894379 | ||
| Emotional symptoms, quality of life and cytokine profile in hemodialysis patients | Q48923359 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| hemodialysis patient | Q126109077 | ||
| P304 | page(s) | 12250 | |
| P577 | publication date | 2018-08-16 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Differential expression of serum biomarkers in hemodialysis patients with mild cognitive decline: A prospective single-center cohort study | |
| P478 | volume | 8 |
Search more.